EB Pharma Developments
Timeline
9 events since 2022Filings
Financial
Establishments
20222023202420252026
The 2026 accounts are due by 31-07-2027.
2026
Registered in the Peppol Directory Reachable for e-invoices through 0208:0780755671
Annual accounts 2025 filed PDFabbreviated format · 128 days before the deadline
2025
Annual accounts 2024 filed PDFabbreviated format · 6 days before the deadline
2024
Back to profit net €3,567 The net result is €3,567, after one loss-making year.
Annual accounts 2023 filed PDFabbreviated format · 1 day before the deadline
2023
Weakest financial year net -€4,644 The net result drops to -€4,644, the lowest from 2022 to 2025. It recovers the following year.
Annual accounts 2022 filed PDFmicro format · 22 days late
2022
IncorporationFounding capital of €1,500, 100 shares · Founded by (sole founder) · appointed as director · published on 25-01-20223 points ▸
- Founded by (sole founder)
- The founding capital is €1,500, divided into 100 shares
- appointed as director
- The deed holds 3 more points.
First establishment Alkerstraat 28, Alken
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank